Terumo Corp (4543) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
November 2018
39
About the Report
About the Report
Summary
Terumo Corp (Terumo) is a medical technology company, which manufactures and sells a wide range of medical care products including hospital and medical products, and equipment. Its major product categories include vascular interventional products, cardiovascular surgical systems, artificial vascular grafts, blood transfusion systems, infusion systems, nutritious food, diabetes monitoring and treatment devices, cancer pain management systems, home oxygen therapy systems and consumer healthcare products. The company's systems find application in and interventional therapies performed inside blood vessels and cardiac and vascular surgery. Terumo also operates blood centers for collecting blood and processing for addressing the transfusion requirement of patients. The company operates through its subsidiaries and associate companies in Japan, China, Europe, North America, South America, and Asia (excluding China and Japan). Terumo is headquartered in Tokyo, Japan.
Terumo Corp (4543)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Terumo Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Terumo Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Terumo Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Terumo Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Terumo Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Terumo Corp, Medical Devices Deals, 2012 to YTD 2018 9
Terumo Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Terumo Corp, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
UniCAR Enters into Agreement with Terumo BCT 11
Cognate Bioservices to Enter into Agreement with Terumo BCT 12
Terumo Enters into Distribution Agreement with Piramal Critical Care 13
Cognate Bioservices Enters into Agreement with Terumo BCT 14
Phosphagenics Enters into Agreement with Terumo 15
Daiichi Sankyo Enters Into Co-Development Agreement With Terumo For Intradermal Vaccine 16
Asset Transactions 17
Thoratec Acquires DuraHeart II Ventricular Assist System From Terumo For USD 56.5 Million 17
Acquisition 19
Terumo BCT To Acquire Gada Turkey, Medical Device Distributor 19
Terumo BCT Acquires Medservice, Distributor Of Medical Products 20
Terumo Corp-Key Competitors 21
Terumo Corp-Key Employees 22
Terumo Corp-Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Joint Venture 28
Recent Developments 29
Strategy And Business Planning 29
Dec 13, 2017: Terumo Constructs a New Building in Yamaguchi, Japan To Strengthen Production Operations in Interventional Systems 29
Jan 31, 2017: Terumo Opens a Branch in Yangon 30
Financial Announcements 31
Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017 31
Corporate Communications 32
Aug 16, 2018: President and CEO of Terumo BCT David Perez to Retire after FY 2018 Antoinette Gawin Named as Successor 32
Aug 15, 2018: David Perez to retire as President and CEO of Terumo BCT on March 31, 2019; Antoinette Gawin named successor 33
Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers 34
Legal and Regulatory 36
Nov 14, 2018: Terumo announces GMP certification has been awarded for the manufacturing and filling of premixed intravenous solutions from the FDA (U.S.A.) 36
Other Significant Developments 37
Jul 09, 2018: Terumo to Increase Production Capacity for Alliance Business Pre-filled Syringes Capital Investment of 7 Billion Yen in Terumo Yamaguchi D&D Corporation 37
Oct 10, 2017: Terumo Provides Update on Impact from Hurricane Maria 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39
List of Figure
List of Figures
Terumo Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Terumo Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Terumo Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Terumo Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Terumo Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Terumo Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Terumo Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Terumo Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Terumo Corp, Medical Devices Deals, 2012 to YTD 2018 9
List of Table
List of Tables
Terumo Corp, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Terumo Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Terumo Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Terumo Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Terumo Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Terumo Corp, Medical Devices Deals, 2012 to YTD 2018 9
Terumo Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
UniCAR Enters into Agreement with Terumo BCT 11
Cognate Bioservices to Enter into Agreement with Terumo BCT 12
Terumo Enters into Distribution Agreement with Piramal Critical Care 13
Cognate Bioservices Enters into Agreement with Terumo BCT 14
Phosphagenics Enters into Agreement with Terumo 15
Daiichi Sankyo Enters Into Co-Development Agreement With Terumo For Intradermal Vaccine 16
Thoratec Acquires DuraHeart II Ventricular Assist System From Terumo For USD 56.5 Million 17
Terumo BCT To Acquire Gada Turkey, Medical Device Distributor 19
Terumo BCT Acquires Medservice, Distributor Of Medical Products 20
Terumo Corp, Key Competitors 21
Terumo Corp, Key Employees 22
Terumo Corp, Other Locations 25
Terumo Corp, Subsidiaries 26
Terumo Corp, Joint Venture 28
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.